KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Charles River Laboratories International (CRL) over the last 16 years, with Q3 2025 value amounting to $55.6 million.

  • Charles River Laboratories International's Income towards Parent Company fell 2096.74% to $55.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$79.6 million, marking a year-over-year decrease of 11860.32%. This contributed to the annual value of $25.3 million for FY2024, which is 9473.51% down from last year.
  • Latest data reveals that Charles River Laboratories International reported Income towards Parent Company of $55.6 million as of Q3 2025, which was down 2096.74% from $52.7 million recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Income towards Parent Company ranged from a high of $189.1 million in Q4 2022 and a low of -$213.7 million during Q4 2024
  • For the 5-year period, Charles River Laboratories International's Income towards Parent Company averaged around $80.6 million, with its median value being $94.3 million (2024).
  • In the last 5 years, Charles River Laboratories International's Income towards Parent Company soared by 4894.19% in 2022 and then crashed by 21312.24% in 2024.
  • Over the past 5 years, Charles River Laboratories International's Income towards Parent Company (Quarter) stood at $139.8 million in 2021, then surged by 35.24% to $189.1 million in 2022, then dropped by 0.08% to $189.0 million in 2023, then crashed by 213.12% to -$213.7 million in 2024, then skyrocketed by 125.99% to $55.6 million in 2025.
  • Its Income towards Parent Company was $55.6 million in Q3 2025, compared to $52.7 million in Q2 2025 and $25.9 million in Q1 2025.